Lummis Asset Management »

Vertex Pharmaceuticals Incorporated shares owned by Lummis Asset Management

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Lummis Asset Management from 13F filings

Historical chart of Lummis Asset Management investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Lummis Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Lummis Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $12k 29 418.00
2023-12-31 $12k 29 406.90

More positions owned by Lummis Asset Management

Matador Resources (MTDR)
Apple (AAPL)
Microsoft Corporation (MSFT)
Berkshire Hathaway Cl B Com Class B
Oracle Corporation (ORCL)
Alphabet Inc Class C Com Class C (GOOG)
Amern Tower Corp Class A Com Class A (AMT)
American International (AIG)
General Dynamics Corporation (GD)
Ross Stores (ROST)
Acushnet Holdings Corp (GOLF)
Pepsi (PEP)
Acuity Brands (AYI)
Schwab Strategic Tr sht tm us tres (SCHO)
Thermo Fisher Scientific (TMO)

View all positions for Lummis Asset Management

Top funds holding Vertex Pharmaceuticals Incorporated

Vanguard Group
BlackRock
FMR
Alliancebernstein
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Jennison Associates
T. Rowe Price Associates
Amundi
Morgan Stanley
Loomis, Sayles and
Massachusetts Financial Services
Bank of America Corporation
Henderson Group

View all funds holding Vertex Pharmaceuticals Incorporated